Urinary Bladder, Overactive: all 864 studies
Page 6 of 9. Open to participants first (125), then studies with results posted, then the rest; newest registration first within each.
- Overactive Bladder Syndrome: Incobotulinumtoxin Versus OnabotulinumtoxinStatus unknownNCT03758235Phase 3
- Oral vs Intravesical Analgesia for Office Bladder Botox InjectionsStatus unknownNCT03755089Phase 4
- Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive BladderWithdrawnNCT03753750Not applicable
- Central Obesity in Cases of OABCompletedNCT03750604Not applicable
- Comparison of Two Forms of Transcutaneous Electrical Stimulation in Overactive BladderStatus unknownNCT03742206Not applicable
- TPTNS: Home vs Hospital Treatment for Overactive BladderStatus unknownNCT03727711Not applicable
- Direct Full-stage Implantation of Sacral NeuromodulationWithdrawnNCT03697954
- Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder SyndromeWithdrawnNCT03695822Phase 4
- Effects of Connective Tissue Massage in Women With Overactive BladderStatus unknownNCT03695692Not applicable
- Group Medical Visits for Latina Women With Urgency Urinary IncontinenceTerminatedNCT03687164Not applicable
- Behavioural Therapy With Checklist for Overactive BladderCompletedNCT03662893Not applicable
- Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary IncontinenceCompletedNCT03643380Phase 1
- Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURPStatus unknownNCT03632772Phase 2
- Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic TestingCompletedNCT03625843Not applicable
- Fluids Affecting Bladder Urgency and Lower Urinary SymptomsCompletedNCT03625492Not applicable
- Sacral Neuromodulation & UrodynamicsStatus unknownNCT03614767
- Sacral Neuromodulation and Pudendal Somatic AfferentsStatus unknownNCT03614754
- Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia OceaniaCompletedNCT03602508
- A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)CompletedNCT03594058Phase 2
- A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and ChinaCompletedNCT03572231
- A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive BladderCompletedNCT03566134Phase 2
- Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female PatientsCompletedNCT03560778
- Condensed Percutaneous Tibial Nerve Stimulation (PTNS) ProtocolTerminatedNCT03559946Not applicable
- Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive BladderCompletedNCT03558919Phase 4
- Retrospective Study of Prescribed Physical Activity in Patients With Overactive Bladder Syndrome Monitored Within the Pelvi-perineology Network in Dijon: Evaluation of Prescription Compliance and Impact on Quality of LifeStatus unknownNCT03552172
- Training and Counseling Program for Overactive Bladder TreatmentCompletedNCT03544554Not applicable
- Effectiveness of a Structured Intervention to Optimize the Use of MirabegronCompletedNCT03536494Not applicable
- Trigonal vs Non Trigonal Botox Injection in OAB.CompletedNCT03533062Not applicable
- Herbal Patch for Overactive BladderCompletedNCT03532789Phase 2/3
- Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic PainCompletedNCT03520166Not applicable
- Electrostimulation in the Treatment of Idiopathic Overactive BladderTerminatedNCT03519126Not applicable
- Efficacy of Different Electrical Stimulation Placement in Patients With Overactive Bladder SyndromeStatus unknownNCT03516435Not applicable
- Assessment of Potential Biomarkers in Women With Symptoms of Overactive Bladder and Pelvic Organ ProlapseStatus unknownNCT03516292
- Sexual Function Trial of Overactive Bladder: Medication Versus PTNSCompletedNCT03500146
- Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivityStatus unknownNCT03486639
- Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord InjuryCompletedNCT03482037Phase 1/2
- Tactile Imaging and ElectromyographyCompletedNCT03477214
- Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult WomenCompletedNCT03475706Phase 2
- Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation StudyCompletedNCT03473782
- Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder SyndromeStatus unknownNCT03468465Phase 4
- Reproductibility of Cystometry in Multiple Sclerosis PatientCompletedNCT03451175
- Experience Sampling Method in OAB PatientsStatus unknownNCT03435991
- Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's DiseaseStatus unknownNCT03412513Phase 4
- Lidocaine for Pain After Urodynamic TestingCompletedNCT03390790Phase 4
- Efficacy of Two Onabotulinum Toxin DosesCompletedNCT03388086
- Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility StudyStatus unknownNCT03385460Not applicable
- Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive BladderCompletedNCT03371342Phase 1
- Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder SyndromeStatus unknownNCT03331081Not applicable
- Efficacy of Lower Limb Exercises on Overactive Bladder Symptoms in Patients With Multiple SclerosisStatus unknownNCT03322748Not applicable
- Visceral Adiposity Index and Overactive BladderCompletedNCT03280654
- Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After SurgeryStatus unknownNCT03280316Not applicable
- Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive BladderStatus unknownNCT03260907Not applicable
- Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime DosingStatus unknownNCT03251300Phase 4
- Physiotherapy in Overactive Bladder: Electrical Stimulation TreatmentCompletedNCT03250650Not applicable
- Laser Treatment of Genito-urinary Syndrome in WomenWithdrawnNCT03238053Not applicable
- Comparison of Craniosacral Therapy vs Pelvic Floor Physical TherapyStatus unknownNCT03213522Not applicable
- Standardization of Lead Placement for Sacral Neuromodulation Part 2Status unknownNCT03199443
- Standardization of Lead Placement for Sacral Neuromodulation. Part 1Status unknownNCT03194425Not applicable
- Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord InjuryCompletedNCT03168828Phase 1
- Clinical and Urodynamic Predictors for Sacral Neuromodulation Outcomes in Overactive BladderStatus unknownNCT03156088
- Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested NeedCompletedNCT03136601Not applicable
- Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive BladderCompletedNCT03109379Phase 1
- Study of ONO-8577 in Patients With Overactive BladderCompletedNCT03106623Phase 2
- Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in FemalesCompletedNCT03104101Not applicable
- Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive BladderWithdrawnNCT03087578Not applicable
- Sensitivity of Extended Cultures in Diagnosing Urinary Tract InfectionsTerminatedNCT03080389
- Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical ProstatectomyStatus unknownNCT03061760
- Mirabegron Treatment on Patients With Overactive Bladder Syndrome in TaiwanCompletedNCT03059134Phase 3
- Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) StudyCompletedNCT03057158
- Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in TaiwanStatus unknownNCT03044912Phase 3
- Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)CompletedNCT03043287
- Diagnosis of Bladder Pain Syndrome / Interstitial CystitisCompletedNCT03023241Not applicable
- Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1WithdrawnNCT03019094Not applicable
- Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OABCompletedNCT03017170Phase 1
- IVES for Treatment of UUI and OABCompletedNCT02992509Early Phase 1
- Low-level Light Therapy for Overactive Bladder and Urinary IncontinenceStatus unknownNCT02980328Phase 3
- A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided TechniqueStatus unknownNCT02946723Phase 1
- Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male VolunteersCompletedNCT02940314Phase 1
- Evaluate the Safety, Tolerability and PK of Different Formulations of Orally Administered Solabegron in Healthy Male SubjectsCompletedNCT02938507Phase 1
- A Study of Transcutaneous Electrical Nerve Stimulation for Overactive BladderTerminatedNCT02922842Not applicable
- Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized TrialStatus unknownNCT02873312Not applicable
- Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery DiseaseCompletedNCT02854813
- Urinary Markers of Detrusor Overactivity in Spina Bifida PatientsCompletedNCT02852317
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy SubjectsStatus unknownNCT02821312Phase 1
- Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic CancerTerminatedNCT02805452Phase 3
- Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) SyndromeCompletedNCT02790307Phase 2
- A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)Status unknownNCT02786407Phase 3
- Investigating Central Mechanisms of Overactive Bladder in Adults With Parkinson's DiseaseCompletedNCT02783014
- Urodynamic Testing: Can we Improve Patient Experience?CompletedNCT02742389Not applicable
- Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)CompletedNCT02735499Phase 2
- Comparison of Electrical Pudendal Nerve Stimulation and Tolterodine Tartrate for Urgency-Frequency Syndrome in WomenCompletedNCT02723279Not applicable
- Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedNCT02715024Phase 4
- Urinary Biomarkers in Overactive Bladder in ChildrenStatus unknownNCT02704013Not applicable
- Behavioural Therapy Program for Female Overactive BladderCompletedNCT02701010Not applicable
- Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2")WithdrawnNCT02674269Phase 1/2
- Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive BladderCompletedNCT02673047
- Audiovisual Stimulus During UrodynamicsCompletedNCT02670486Not applicable
- Reproducibility Study of OABSS and Its Response to TreatmentCompletedNCT02667470Phase 4
- Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OABCompletedNCT02657057Not applicable
- Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 AgonistsCompletedNCT02622555